Embed Size (px)
Citation preview
https://alzheimers-dementia.neurologyconference.com/
Tentative Programconferenceseries.com
Theme: “Future of Dementia & Alzheimer: Innovations and Research Outlook”
Alzheimer’s Disease & DementiaMay 24-25, 2018 Vienna, Austria
11th International Conference on
InteractiveSessions
KeynoteLectures
Exhibitors B2BMeetings
PlenaryLectures Workshops
***For available speaker slots***[email protected]
conferenceseries.com
https://alzheimers-dementia.neurologyconference.com
Reception/ Registration Time
09:00-09:1509:15-10:0010:00-10:4510:45-11:30
Symptoms and Diagnosisof Dementia
Alzheimer’s Pathophysiology
Dementia Care Practice & Awareness Workshop
Time Session 1 Session 2Keynote Forum Vascular Dementia
Alzheimer’s Diagnosis and Symptoms Parkinson’s disease
Therapeutic Targets & Mechanisms for Treatment Other Dementia Diseases
Animal Models & Translational Medicine Poster Presentation
Coffee/Tea Break 15.30-15.45 (Networking)
Panel Discussions/Group Photo
Coffee/Tea Break 15:15-15:30 (Networking)
Lunch Break 13:15-13:45
Coffee/Tea Break 11:30-11:45 (Networking)
Least of 3 Keynote/Plenary Talks
15:30-17:00
NOTE: Program Shedule is subject to change with final allotment of the speaker slots
Program at a Glance
General SessionInaugural Address
Keynote/Plenary Talk 1Keynote/Plenary Talk 2Keynote/Plenary Talk 3
Eve
ning
Ses
sion
sM
orni
ng S
essi
ons
Eve
ning
Ses
sion
s
14.25-15.30
15.45-17.00
Day 2
Day 1
11th International Conference on
Alzheimer's Disease & DementiaMarch 29-30, 2018 Vienna, Austria
08.00-09.00
Mor
ning
Ses
sion
s
Dementia-An underlying disease11:45-13:15
12.55-13.35
13:45-15:15
Awards & Closing Ceremony
Coffee/Tea Break 11.40-12.55 (Networking)
Lunch Break 13.35-14.25
09.00-11.40
Euro Dementia 2018
Alzheimer’s Disease & DementiaMay 24-25, 2018 Vienna, Austria
11th International Conference on
conferenceseries.com
https://alzheimers-dementia.neurologyconference.com
Glimpses of Alzheimer’s Disease & Dementia Conferences
Euro Dementia 2018
conferenceseries.com
https://alzheimers-dementia.neurologyconference.com
Euro Dementia 2018
Glimpses of Alzheimer’s Disease & Dementia Conferences
https://alzheimers-dementia.neurologyconference.com
• Dementia-An underlying disease
• Symptoms and Diagnosis of Dementia
• Vascular Dementia
• Alzheimer’s Diagnosis and Symptoms
• Alzheimer’s Imaging and Clinical trials
• Alzheimer’s Pathophysiology
• Parkinson’s disease
• Dementia with Lewy bodies
• Frontotemporal dementia
• Wernicke-Korsakoff Syndrome
• Neurocognitive Disorder
• Dementia Care Practice & Awareness
• Amyloid Protein in Dementia
• Mixed Dementia
• Therapeutic Targets & Mechanisms for Treatment
• Animal Models & Translational Medicine
Major Scientific Sessions
• You will be given about 5-7 minutes to present your poster including questions and answers. Judges may pose questions during the evaluation of the poster• Judges will even evaluate the student’s
enthusiasm towards their study, interest and knowledge in the area of their research
• The winners will be announced at the closing ceremony of the conference. The decision of the winner will be withdrawn if the winner/winners is/are not present at the time of announcement
• Apart from the judging time you may also be present at the poster to share your research with interested delegates
• Present your research through oral presentations • Learn about career development and the latest research
tools and technologies in your field • This forum will give pertinent and timely information
to those who conduct research and those who use and benefit from research
• Develop a foundation for collaboration among young researchers
• The forum will provide an opportunity for collegial interaction with other young investigators and established senior investigators across the globe
• Interact and share ideas with both peers and mentors
General [email protected]
Best Poster Award Young Researchers Forum
Conference VenueVienna, Austria
Contact usAmerica: Conference Series LLC
Euro Dementia 2018Conference Series - America
One Commerce Center-1201, Orange St. #600, Wilm-ington,
Zip 19899, Delaware, USAP: +1-702-508-5200, F: +1-650-618-1417
Email: [email protected]
Contact usConference Series - UK
Euro Dementia 2018Kemp House, 152 City Road, Vienna EC1V 2NX, UK
P: +1-702-508-5200, Toll Free: +1-800-014-8923 Email: [email protected]
Contact us Asia-Pacific: Conference Series LLC
Euro Dementia 2018Divyasree Building, Raidurg
6th Floor, North Block Hyderabad 500032, INDIA
Tel: 040-33432309Email: [email protected]
conferenceseries.com
https://alzheimers-dementia.neurologyconference.com
Best Tourist Destinations in Vienna
Hofburg
Kunsthistorisches Museum
Prater
Austrian National Library
St. Stephen’s Cathedral
Imperial Treasury
Euro Dementia 2018
conferenceseries.com
Conference Series-AmericaOne Commerce Center-1201, Orange St. #600, Wilmington, Zip 19899, Delaware, USA
Toll Free: 1-888-843-8169, P: 702-508-5200, F: +1-650-618-1417
Conference Series-UKKemp House, 152 City Road, London EC1V 2NX, UK
Toll Free: +0-800-014-8923
Scientific Program1319th Conference
October 16-18, 2017 | Rome, Italy
9th International Conference on
Alzheimer’s Disease & Dementia
Page 8
RegistrationsDay 1 October 16, 2017
Keynote ForumIntroductionTitle: APP intracellular domain supperess neuronal differentiation through transcriptional regulation of mir663Zhicheng Xiao, Monash University, AustraliaTitle: Masked hypertension is associated with cognitive decline in geriatric ageMustafa Cankurtaran, Hacettepe University, Turkey
Networking and Refreshments BreakTitle: The Dementia alliance for Culture and Ethnicity: A UK Call to Action on responding to the impact of Dementia in Black, Asian and minority ethnic communitiesDavid Truswell, PLIAS Resettlement, UKSessions: Alzheimers: Causes, Prevention and Management of DementiaSession Chair: Mustafa Cankurtaran, Hacettepe University, Turkey
Session IntroductionTitle: Aromatherapy versus pharmaceutical interventions for Dementia related behaviorsVanessa Veit, Massachusetts College of Pharmacology, USATitle: Memory is really not lost in Alzheimer’s patients as memory is related to the mind which is infinite, immortal and is not limited to the body or the brain. Shyamala Mruthinti, Emory University, USATitle: GAPDH mRNA expression in blood of Moroccan AD casesNadia El Kadmiri, IBN ZOHR University, Morocco
Lunch BreakTitle: Unified theory of Alzheimer's disease: Evolution is the key to Alzheimer's prevention and early treatmentJennie Ann Freiman, Mount Sinai School of Medicine, USATitle: Gender differences in persons with Dementia including Alzheimer’s disease who go missing: Implications for managing DementiaStephen J Morewitz, California State University, USASessions:Alzheimers Disease Diagnosis, Imaging and Clinical TrailsSession Chair: Mustafa Cankurtaran, Hacettepe University, Turkey
Session IntroductionTitle: Midlife insulin resistance increases the risk for brain amyloid accumulation in carriers and non-carriers of APOEε4 genotype – A follow-up study of 15 yearsLaura Ekblad, University of Turku, FinlandTitle: Can musical or painting interventions reduce pain or improve mood, quality of life and cognition in patients with mild Alzheimer’s disease?Isabelle ROUCH, Saint Etienne University Hospital, France
Networking and Refreshments Break
Opening Ceremonyconferenceseries.com
@ Olimpica 1
Page 9
Title: Effectiveness and cost-effectiveness of an in-home respite care program in supporting informal caregivers of people with Dementia: Design of a comparative studySophie Vandepitte, Ghent University, BelgiumTitle: Interactions of intracellular amyloid beta peptides and biomarkers of Alzheimer disease in cerebrospinal fluidZdenka Kristofikova, National Institute of Mental Health, Czech RepublicTitle: Computerised analysis of conversational trouble and repair in people with dementia and their carersHelen Chenery, Bond University, AustraliaTitle: Microbiological and immunological aspects of Alzheimer's diseaseOleksandr Makarenko, University of Pereyaslav-Khmelnitskiy, Ukraine
Panel Discussion Day 2 October 17, 2017
@ Olimpica 1Sessions: Geriatrics and Care Practice and AwarenessSession Chair: David Truswell, PLIAS Resettlement, UK
Session IntroductionTitle: Masked hypertension is associated with cognitive decline in geriatric ageMustafa Cankurtaran, Hacettepe University, TurkeyTitle: Stochastic modeling of signaling pathways and gene expression mechanisms in Alzheimer’s disease using continuous time markov chainsSahil Doshi, Upper St. Clair High School, USA
Networking and Refreshments BreakTitle: A study on stress, burden, social support and the desire to institutionalization among caregivers of persons with DementiaSherin Yohannan, National Institute of Mental Health and Neurosciences, IndiaTitle: Paratonia in Flemish nursing homes: State of the artBieke Van Deun, Ghent University, Belgium
Poster Presentations Session I
PP1Title: Galantamine potentiates neuroprotective potential of Taurine in Aβ (1-42) induced animal model of Alzheimer’s disease: The synergistic role of GABAA & α 7 nicotinic acetylcholine receptorsArti Singh, Panjab University, India
PP2Title:Serum levels of natural ocurring IgG against neuronal antigens, Amyloid β peptide and Aldolase in Cubans over 60 years oldLeonardo Cristia Lara, University of Zurich, Switzerland
PP3Title: Gender differences in persons with Dementia including Alzheimer’s disease who go missing: Implications for managing DementiaStephen J. Morewitz, California State University, USA
PP4Title: Paratonia in Flemish nursing homes: State of the artBieke Van Deun, Ghent University, Belgium
PP5Title: Potentials of Gangetin based Phytopharmaceutical formulation Mysgan-2 in management of DementiaHanumanthachar Joshi, Sarada Vilas College of Pharmacy, India
PP6Title: Beneficial interaction between B vitamins and omega-3 fatty acids in slowing brain atrophy and cognitive decline in subjects with Mild Cognitive Impairment (MCI)Abderrahim Oulhaj, United Arab Emirates University, UAE
PP7Title: Survey of cognitive rehabilitation practices in the state of KuwaitFahad Safah Kayed Manee, Kuwait University, Kuwait
PP8Title: The study of association between serum brain derived neurotrophic factor protein and dyslipidemia on memory performance in thai Alzheimer disease patientsPanaree Busarakumtragul, Srinakharinwirot University, Thailand
Page 10
PP9Title: Cerebral smallvessels disease in Alzheimer’s diseaseIvan V. Maksimovich, Most Holy John Tobolsky, Russia
PP10Title: The application of Transcatheter Laser Revascularization for the restoration of cerebral microcirculation, tissue structure and the mitochondrial cellular apparatus in ADIvan V. Maksimovich, Most Holy John Tobolsky, Russia
PP11Title: Protective Effect of Atorvastatin on D-galactose-Induced Aging Model in MiceIman Fatemi, Rafsanjan University of Medical Sciences, Iran
PP12Title: Ampakine Farampator (CX691) improves cognitive impairment and hippocampus BDNF levels in a rat model of Aε1-42-induced Alzheimer's diseaseAyat Kaeidi, Rafsanjan University of Medical Sciences, Iran
Lunch BreakPoster Presentations Session II
PP13Title: Challenging the neuroprotective potential of physical exercise: Insights into plasticity-related mechanisms in the aging brainYulia Lerner, Tel Aviv University, Israel
PP14Title: In vivo studies to assess the protective influence of Lactobacillus plantarum MTCC1325 on Alzheimer’s diseaseMallikarjuna Nimgampalle, Sri Venkateswara University, India
PP15Title: Neuroprotective activity of novel 1,2,4-triazine derivatives against H2O2 and Aβ-induced neurotoxicity, new leads for Alzheimer’sHamid Irannejad, Mazandaran University of Medical Sciences, Iran
PP16Title: Stochastic modeling of signaling pathways and gene expression mechanisms in Alzheimer’s disease using Continuous Time Markov ChainsSahil Doshi, Upper St. Clair High School, USA
PP17Title: Dignity-preserving dementia care: A metasynthesisOscar Tranvåg, University of Bergen, Norway
PP18Title: Neuroinflammation & Alzheimer’s diseaseMai Mwafy, Bristol School of Medicine, UK
PP19Title: Neuroinflammation & Alzheimer’s diseaseNoura AL Mulhim, Bristol School of Medicine, UK
PP20Title: A study on stress, burden, social support and the desire to institutionalization among caregivers of persons with DementiaSherin Yohannan, National Institute of Mental Health and Neurosciences, India
PP21Title: Interactions of intracellular amyloid beta peptides and biomarkers of Alzheimer disease in cerebrospinal fluidZdenka Kristofikova, National Institute of Mental Health, Czech Republic
PP22Title: Sphingosine-1-phosphate receptor 1 (S1PR-1): A new target for the treatment of Tau-related pathologiesGuy Massicotte, University of Quebec, Canada
PP23Title: The role of animal models in neuropsychiatric research Tejkalová Hana, National Institute of Mental Health, Czech Republic
PP24Title: Men with experience preparing meals show greater functional independence in mild cognitive impairmentKonstantine Zakzanis, University of Toronto Scarborough, Canada
PP25Title: Effect of using (physical-skill) training for developed the performance according to several Biomechanics Volatiles with Foil Lunch accuracySarko Mohammed Salih, University of Sulaymaniyah, Iraq
Sessions: Geriatrics and Care Practice and Awareness
Page 11
Session Chair: David Truswell, PLIAS Resettlement, UKSession Introduction
Title: Oral Narratives of Indigenous female cargivers for a loved one diagnosed with Alzheimer’s disease and other dementias (ADOD)Danielle Alcock, Western University, Canada
Networking and Refreshments BreakTitle: The risk of fall by dementia, comorbidities, and sedative medicines among home-dwelling older people in Denmark - A Danish register-based case-control studyJindong Ding Petersen, University of Southern Denmark, Denmark Title: Survey of cognitive rehabilitation practices in the state of KuwaitFahad Safah Kayed Manee, Kuwait University, KuwaitTitle: Dignity-preserving dementia care: A metasynthesisOscar Tranvag, University of Bergen, Norway Title: The role of animal models in neuropsychiatric research Tejkalová Hana, National Institute of Mental Health, Czech Republic
Day 3 October 18, 2017@ Olimpica 1
Sessions: Amyloid Protein in Alzheimers and DementiaSession Chair: Linda Levine Madori, St. Thomas Aquinas College, USA
Session IntroductionTitle: The TTAP Method; A proven structured non-pharmaceutical approach to enhancing cognition and socialization in mild-moderate Stages of Alzheimer’s diseaseLinda Levine Madori, St. Thomas Aquinas College, USA
Networking and Refreshments BreakTitle: Alzheimer’s cognitive impairment can be recovered by decreasing homocysteic acid In bloodTohru Hasegawa, Saga Woman Junior College, JapanTitle: Efficacy and safety of MMFS-01, A synapse density enhancer, for reversing age-related cognitive decline: a randomized, double-blind, placebo-controlled trialGuosong Liu, Tsinghua University, ChinaTitle: Interaction of soluble and Amyloid form of serum Amyloid a protein to neuro 2a cells Asokan Chinnasamy, Sokoto State University, Nigeria
Lunch BreakPanel Discussion
Awards & Closing Ceremony
conferenceseries.com710th Conference
5th International Conference on
Alzheimer’s Disease &Dementia
September 29-October 01, 2016 London, UK
Proceedings of
Hosting Organization: Conference Series LLC2360 Corporate Circle., Suite 400 Henderson, NV 89074-7722, USA
Ph: +1-702-508-5200 Ext: 8034, Fax: +1-650-618-1417, Toll free: +1-800-216-6499
Conference Series LtdHeathrow Stockley Park Lakeside House, 1 Furzeground Way
Heathrow, UB11 1BD, UK, Tel: +1-800-216-6499Email: [email protected]; [email protected]
Supporting Sponsors
Scientific Program
Page 13
Keynote ForumIntroductionClaude M Wischik, TauRx Therapeutics, UK
Title: Dendrimer’s –New hope in the treatment of Alzheimer’s diseaseJerzy Leszek, Wroclaw Medical University, Poland
Title: Alternative Models for Drug Discovery in Alzheimer’s DiseaseJordan L Holtzman, University of Minnesota, USA
Networking and RefreshmentsSessions: Causes and Prevention | Managing DementiaSession Chair: Claude M Wischik, TauRx Therapeutics, United KingdomSession Chair: Jerzy Leszek, Wroclaw Medical University, Poland
Session IntroductionTitle: Managing behavioral disturbance with the dementia client through Person-centered care modelClaire Henry, Lourdes Memory Center, USATitle: Depression predicts imminent conversion from mild cognitive impairment to Alzheimer´s diseaseMichaela Defrancesco, Medical University of Innsbruck, AustriaTitle: An interventional study to promote appropriate use of psychotropic drugs in care homes in people with dementiaDebjani Banerjee Gangopadhyay, University of the West of Scotland, UKTitle: Potential Benefits of Functional Task Exercise on Cognition and Functional Status of Older Adults with Mild Cognitive ImpairmentLawla LF Law, Tung Wah College, Hong Kong
Group PhotoLunch Break
Title: Importance of developing skills of Dementia care workers for providing palliative care in DementiaSangeeta Semwal, Saathi Care & Nursing Private Limited, IndiaTitle: To Investigate Role of Glycosylated Hemoglobin(HbA1C) as a Biomarker for prediction of Dementia &Cognitive Dysfunction in Type 2 Diabetic PatientsAman Gupta, Amity University, IndiaTitle: Pharmaceutical effect of Murraya Koenigii on Alzheimers disease- A reviewAnanya Bagchi, IIT Kharagpur, IndiaTitle: Risk factors in induction and progression of Alzheimer’s disease: Impact on protection and disease-modifying factorsAzza A Ali, Al-Azhar University, EgyptTitle: A Major Early Driver of Tauopathy and Neurodegeneration that is Blocked by AntibodyKoorosh Shahpasand, Royan Institute for Stem Cell Biology and Technology, IranSpecial Session by Lew LimVielight Inc, Canada
Networking & Refreshment Break
Workshop on Wake up London – Raising awareness of dementia in London’s Black, Asian and Minority ethnic communitiesDavid Truswell, Central and North West London NHS Foundation Trust, UK
Sessions: Amyloid Protein in Dementia | Therapeutic Targets | Imaging TechniquesSession Chair: Jerzy Leszek, Wroclaw Medical University, PolandSession Chair: Zhicheng Xiao, Monash University, Australia
RegistrationsDay 1 September 29, 2016
Concorde Suite 2&3
Opening Ceremonyconferenceseries.com
Scientific Program
Page 14
Session IntroductionTitle: ACAT1/SOAT1 as a therapeutic target for Alzheimer's diseaseT Y Chang, Geisel School of Medicine at Dartmouth, USATitle: Imputation and Censored Covariate: Application to Alzheimer StudyFolefac Atem, University of Texas Health Science Center, USATitle: A scFv antibody targeting common oligomeric epitope has potential for treating several amyloidosesXiao-lin Yu, Chinese Academy of Sciences, ChinaTitle: Rivastigmine and Citalopram treatment for Alzheimer’s disease (AD) in daily clinical practiceKrishna Prasad Pathak, Amity Global education, Nepal
Panel Discussion
Day 2 September 30, 2016
Concorde Suite 3Keynote Forum
Title: Utilizing the TTAP method to enhance collective impact on a Dementia and gero-psychiatic unit; increasing interactions and involvement while decreasing falls
Linda Levine Madori, St Thomas Aquinas College, USA
Title: Neurodegeneration research: From molecules, big animal models to human beings
Zhicheng Xiao, Monash University, Australia
Title: Study on Diabetes Induced Dementia and the Mechanisms of Synaptic Plasticity in KK-Ay Mice
Xiaoliang Wang, Chinese Academy of Medical Sciences, ChinaNetworking and Refreshments
Sessions:Animal Models and Translational Medicine | Pathophysiology and Disease Mechanisms | Diagnosis and SymptomsSession Chair: Linda Levine Madori, St Thomas Aquinas College, USASession Co-chair: Mourad Tayebi, The University of Melbourne, Australia
Session IntroductionTitle: Neuroprotective and Neurorestorative effects of disease-modifying single-domain Antibody fragments in Aged BeaglesMourad Tayebi, The University of Melbourne, AustraliaTitle: Recovery and immunological properties of “Cerebral” under the acute strokeOleksandr Makarenko, Taras Shevchenko National University of Kyiv, UkraineTitle: The projection from postrhinal cortex to ventral lateral orbitofrontal cortex impacts on spatial memoryQI Xinyang, Southeast University, ChinaTitle: Ins2 gene expression and function in the mouse brainSunday A Ajayi, University of British Columbia, CanadaTitle: Platelet CD40L mediates activation of Astrocytes and Microglia culminating in Neuronal injury in brain regions associated with Memory functions during Chronic HypertensionShahnawaz Ali Bhat, CSIR-Central Drug Research Institute, IndiaTitle: Effect of Medlar (Mespilus germanica L) fruit and seed flavonoids on learning and memory and also hippocampal CA3 neurons in Alzheimer’s ratsMatin Ramezani, Arak University, Iran
Lunch Break 13:20-14:00 @ Aromi RestaurantTitle: Development of combined therapy for Alzheimer’s disease: A mechanistic studyZhengnan Shan, University of South Australia, AustraliaTitle: The in vivo triad behind the neuromodulatory effect of Bauhinia variegata L.Alaa Selim, German University in Cairo, EgyptWorkshop on A Pharmacoeconomical Approach To Dementia: A Review Of The Current Pharmacological And Non-Pharmacological Managements – A Cost-Benefit AnalysisLuis Angel Francisco Sorroza Lopez, University La Salle Mexico, MexicoSpecial Session by Hayley Riley and Louise EvansHaylo Theatre, United Kingdom
Networking and Refreshments
Page 15
Poster Presentations:Poster Judge: Jerzy Leszek, Wroclaw Medical University, PolandPoster Judge: Linda Levine Madori, St Thomas Aquinas College, USA
ADD-01Title: Primary and secondary prevention interventions for cognitive decline and dementia- An overviewFlodgren Gerd, National Institute of Public Health, Norway
ADD-02Title:Cognitive impairment is correlated with and unstable mental health profileEtindele Sosso Faustin Armel, University of Montreal, Canada
ADD-03Title: Effect of non-pharmacological interventions on functional performance in mild cognitive impairment (MCI): A scoping reviewNavaldeep Kaur, McGill University, Canada
ADD-04Title: A Multifaceted rehabilitation model in Alzheimer’s Disease maintains brain speed over 60 Months: A case reportValentin Bragin, Stress Relief and Memory Training Center, USA
ADD-05Title: Systematic review of positive psychology outcome measures for family carers of people with dementiaJacki Stansfeld, University College London, UK
ADD-06Title: Trends of Successful Exelon (Rivastigmine) patch in Geriatric patients with DementiaJanice Hoffman, Western University of Health Sciences, USA
ADD-07Title: Oxidative modification of γ-secretase enhances amyloidogenic pathwayHarkkyun Kim, Sungkyunkwan University School of Pharmacy, Republic of Korea
ADD-08Title: Neurocognitive Markers in Early Diagnosis of Alzheimer’s DiseasePooja Rai, Banaras Hindu University, India
ADD-09Title: Role of Presenilin-1 Mutations in Mitochondrial DynamicsHeejin Park, Sungkyunkwan University, Republic of Korea
ADD-10Title: Vitamin D and resveratrol prevents cognitive decline via reduces APP amyloidogenic processing in the SAMP8 miceLili Xin, Soochow University, China
ADD-11Title: The Role of Mental and Physical Activities against Development of Alzheimer’s disease in Socialized and Isolated RatsAzza A Ali, Al-Azhar University, Egypt
ADD-12Title: Study on Social Isolation as a Risk Factor in Alzheimer's disease Azza A Ali, Al-Azhar University, Egypt
ADD-13Title: Inhibition of mitochondrial fission ameliorates the pathogenesis of Alzheimer’s diseaseHeejin Park, Sungkyunkwan University, Republic of Korea
ADD-14Title: XHC restores cognition of Alzheimer’s disease mice and reduces amyloid beta burden via repressing BACE1 promoter activityGun Young Jung, Sungkyunkwan University School of Pharmacy, Republic of Korea
ADD-15Title: RA improves cognitive function of Alzheimer’s disease mouse model through inhibition of BACE1 expression and neuroinflammationGun Young Jung, Sungkyunkwan University School of Pharmacy, Republic of Korea
ADD-16
Title: The combination of 1α,25dihydroxyvitaminD3 with resveratrol prevents endoplasmic reticulum stress-mediated neuronal degeneration by improving insulin signaling and inhibiting tau hyperphosphorylation in SH-SY5Y cellsZhongxiao Wan, Soochow University, China
ADD-17Title: SH2B1 is involved in the accumulation of Aβ42 in Alzheimer’s disease modelWen-An Wang, Shanghai Jiaotong University, China
ADD-18Title: Clinical Usefulness of [18F]FC119S PET as an Auxiliary Diagnostic Methods for DementiaSang Moo Lim, Korea Institute of Radiological and Medical Sciences, Republic of Korea
Day 3 October 01, 2016
Concorde Suite 3
Page 16
Sessions:Geriatrics and Cognitive Disorder | Care Practice and AwarenessSession Chair: Jerzy Leszek, Wroclaw Medical University, PolandSession Co-chair: Anita Saltmarche, Saltmarche Health & Associates Inc., Canada
Session Introduction Title: Impact of Physical and Mental Insults on Dementia: Clinical Observations following a Transcranial-Intranasal Photobiomodulation Therapy StudyAnita Saltmarche, Saltmarche Health & Associates Inc., CanadaTitle: Stop Dementia in it’s Track with Alternative Healing ModalitiesSophia Stavron, StavroHedi LLC, USATitle: Engaging with lived dementia experience through first-person media narrativesGary Morris, University of Leeds, UK
Networking and RefreshmentsTitle: Trends of successful exelon (Rivastigmine) patch in geriatric patients with DementiaJanice Hoffman, Western University of Health Sciences, USATitle: The Relationship between the Number of Chronic Diseases and Living Environment among Dementia PatientsFENG Ze-yun, Shanghai Medical Information Center, ChinaTitle: The National Dementia Strategy: Making it culturally competent for allTiwalola Kolapo, Middlesex University, UKTitle: Systematic review of positive psychology outcome measures for family carers of people with dementia Jacki Stansfeld, University College London, UKTitle: The development of an online information and support program for informal carers of people living with YOD: The RHAPSODY studyBridget Jones, University of Surrey, UK
Lunch BreakTitle: Talking with Dementia: The patterns and characteristics of a unique communicationDaniella Arieli, Emek Yezreel College, IsraelTitle: A case report of delirium superimposed on dementia, in an elderly female patient with venous thrombosis of the legAhmed M Lutfi Al-Imam, University of Baghdad, IraqTitle: Decision on mode of feeding in advanced dementia: Experience of caregivers in the discussion with medical professionKwan Ching Yin Connie, The Chinese University of Hong Kong, Hong KongWorkshop on "Play is the Highest form of research”. How Einstein’s quote inspired me!Laura Templeton, University College London, UK
Networking and RefreshmentsAwards & Closing Ceremony
Website: www.alzheimers-dementia.conferenceseries.comE-mail: [email protected], [email protected]
Bookmark Your Dates
October 16-18, 2017 Rome, Italy
7th International Conference on
Alzheimer’s Disease & Dementia
